The company
Standing Ovation essentially replicates caseins in a lab setting, and it achieves this through a “precision fermentation” process to recreate what is a core ingredient for non-animal, lactose-free dairy substitutes.
The funding
Standing Ovation, based in Paris, France, announced €30M in Series B financing on March 31, 2026.
Participants include Astanor Ventures, Crédit Mutuel Innovation, Angelor, NewTree Impact, GoodStartUp, Noshaq, Ecotechnologies 2 fund, Danone Ventures, Bel Group, Big Idea Ventures, Seventure Partners.